AlzeCure Pharma: New Data from AlzeCure Demonstrate Potentia

STOCKHOLM, SWEDEN / ACCESSWIRE / October 11, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden , Stockholm , Swedish , Pontus Forsell , Sanja Juric , Alzecure Pharma , Johan Sandin , Cristina Parrado , Head Of Research , Brain Derived Neurotrophic Factor , Nasdaq First North Premier Growth Market , Nerve Growth Factor , Alzecure , Dharma , Data , Rom , Emonstrate , Potential , Disease , Modifying , Effects , Neurorestore , Cd856 ,